Basic principles in pharmacology pharmacokinetics - pharmacology
Pharmacology
description
Transcript of Pharmacology
![Page 1: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/1.jpg)
Pharmacology
CRT 11? = 8%
RRT 6?
![Page 2: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/2.jpg)
A 30-year-old patient presents to the asthma clinic with a 2-week history of daily wheezing and nightly awakenings with shortness of breath. The patient is using Primatene Mist five times daily and fluticasone propionate (Flovent) 110 MDI occassionally at night. How should the therapist counsel the patient regarding disease management?
I. Discontinue Primatene Mist II. Use fluticasone propionate (Flovent) 110 MDI, 2 puffs twice
daily.III. Use salmeterol (Serevent) dry powder inhaler, 1 dose twice
daily.IV. Use fluticasone propionate/salmeterol (Advair) 100/50 dry
powder inhaler, one dose daily.
A. I, II, and III only B. I, II, and IV only C. I, III, and IV only D. II, III, and IV only
![Page 3: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/3.jpg)
A 30-year-old patient presents to the asthma clinic with a 2-week history of daily wheezing and nightly awakenings with shortness of breath. The patient is using Primatene Mist five times daily and fluticasone propionate (Flovent) 110 MDI occassionally at night. How should the therapist counsel the patient regarding disease management?
I. Discontinue Primatene Mist II. Use fluticasone propionate (Flovent) 110 MDI, 2 puffs twice
daily.III. Use salmeterol (Serevent) dry powder inhaler, 1 dose twice
daily.IV. Use fluticasone propionate/salmeterol (Advair) 100/50 dry
powder inhaler, one dose daily.
A. I, II, and III only B. I, II, and IV only C. I, III, and IV only D. II, III, and IV only
![Page 4: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/4.jpg)
Which of the following is associated with the administration of aerosolized pentamidine isethionate (NebuPent)?
A.tachycardia B.bradycardia C.bronchospasm D.hypotension
![Page 5: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/5.jpg)
Which of the following is associated with the administration of aerosolized pentamidine isethionate (NebuPent)?
A.tachycardia B.bradycardia C.bronchospasm D.hypotension
![Page 6: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/6.jpg)
An increase in a patient's heart rate during aerosolized bronchodilator therapy is primarily a result of which of the following drug effects?
A.alpha only B.beta 1 only C.beta 2 only D.beta 1 and beta 2 only
![Page 7: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/7.jpg)
An increase in a patient's heart rate during aerosolized bronchodilator therapy is primarily a result of which of the following drug effects?
A.alpha only B.beta 1 only C.beta 2 only D.beta 1 and beta 2 only
![Page 8: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/8.jpg)
Which of the following devices are most commonly used to deliver aerosols by the inhalation route?
I. Dry powder inhalerII. Metered dose inhalerIII. Small-volume nebulizerIV.Slip-stream nebulizer
A. I and IIIB. II and IVC. I, II, and IIID. I, II, III, and IV
![Page 9: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/9.jpg)
Which of the following devices are most commonly used to deliver aerosols by the inhalation route?
I. Dry powder inhalerII. Metered dose inhalerIII. Small-volume nebulizerIV.Slip-stream nebulizer
A. I and IIIB. II and IVC. I, II, and IIID. I, II, III, and IV
![Page 10: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/10.jpg)
Which of the following are the largest single group of drugs among aerosolized agents used for inhalation?A. Inhaled corticosteroidsB. Adrenergic bronchodilatorsC. Mucus-controlling agentsD. Anticholinergic bronchodilators
![Page 11: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/11.jpg)
Which of the following are the largest single group of drugs among aerosolized agents used for inhalation?A. Inhaled corticosteroidsB. Adrenergic bronchodilatorsC. Mucus-controlling agentsD. Anticholinergic bronchodilators
![Page 12: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/12.jpg)
Which of the following is an indication for use of an adrenergic bronchodilator?
A.Treatment of excessive, viscous mucus secretions
B.Antiinflammatory treatment of mild to moderate persistent asthma
C.Treatment of reversible airflow obstructionD.Prophylactic management of asthma
![Page 13: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/13.jpg)
Which of the following is an indication for use of an adrenergic bronchodilator?
A.Treatment of excessive, viscous mucus secretions
B.Antiinflammatory treatment of mild to moderate persistent asthma
C.Treatment of reversible airflow obstructionD.Prophylactic management of asthma
![Page 14: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/14.jpg)
Proventil and Ventolin are brand names for which of the following beta-adrenergic bronchodilators?A. AlbuterolB. IsoetharineC. TerbutalineD. Metaproterenol
![Page 15: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/15.jpg)
Proventil and Ventolin are brand names for which of the following beta-adrenergic bronchodilators?A. AlbuterolB. IsoetharineC. TerbutalineD. Metaproterenol
![Page 16: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/16.jpg)
An MDI of Salmeterol delivers which of the following?A. 131 mg/puffB. 90 mg/puffC. 65 mg/puffD. 25 mg/puff
![Page 17: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/17.jpg)
An MDI of Salmeterol delivers which of the following?A. 131 mg/puffB. 90 mg/puffC. 65 mg/puffD. 25 mg/puff
![Page 18: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/18.jpg)
Which of the following short-acting catecholamines are used for their strong alpha1 vasoconstricting effects to reduce swelling in the nose and larynx and to control bleeding during bronchoscopic biopsy?A. IsoproterenolB. IsoetharineC. DobutamineD. Racemic epinephrine
![Page 19: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/19.jpg)
Which of the following short-acting catecholamines are used for their strong alpha1 vasoconstricting effects to reduce swelling in the nose and larynx and to control bleeding during bronchoscopic biopsy?A. IsoproterenolB. IsoetharineC. DobutamineD. Racemic epinephrine
![Page 20: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/20.jpg)
Which of the following are side effects of newer, more beta2-selective bronchodilators?A. TremorB. InsomniaC. NervousnessD. All the above
![Page 21: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/21.jpg)
Which of the following are side effects of newer, more beta2-selective bronchodilators?A. TremorB. InsomniaC. NervousnessD. All the above
![Page 22: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/22.jpg)
What are some potential adverse effects with use of adrenergic bronchodilators?
I. HypokalemiaII. DizzinessIII. Worsening ventilation/perfusion ratio (V/Q)IV.Bradycardia
A. I and IV onlyB. II and III onlyC. I, II, and IIID. I, II, III, and IV
![Page 23: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/23.jpg)
What are some potential adverse effects with use of adrenergic bronchodilators?
I. HypokalemiaII. DizzinessIII. Worsening ventilation/perfusion ratio (V/Q)IV.Bradycardia
A. I and IV onlyB. II and III onlyC. I, II, and IIID. I, II, III, and IV
![Page 24: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/24.jpg)
Which of the following are assessment features for evaluating patient response to bronchodilator therapy?
I. Reversibility of airflow obstructionII. Changes in flow rates using a peak flow meter or
portable spirometryIII. Vital-sign changes (e.g., blood pressure, pulse rate)IV. Changes in ventilation and oxygenation by arterial
blood gas or pulse oximeterV. The patient's subjective reaction to treatment
A. II, III, and IVB. II, III, and VC. I, II, III, and VD. I, II, III, IV, and V
![Page 25: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/25.jpg)
Which of the following are assessment features for evaluating patient response to bronchodilator therapy?
I. Reversibility of airflow obstructionII. Changes in flow rates using a peak flow meter or
portable spirometryIII. Vital-sign changes (e.g., blood pressure, pulse rate)IV. Changes in ventilation and oxygenation by arterial
blood gas or pulse oximeterV. The patient's subjective reaction to treatment
A. II, III, and IVB. II, III, and VC. I, II, III, and VD. I, II, III, IV, and V
![Page 26: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/26.jpg)
What amount of Ipratropium bromide (Atrovent) is delivered by MDI?A. 10 mg/puffB. 15 mg/puffC. 18 mg/puffD. 90 mg/puff
![Page 27: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/27.jpg)
What amount of Ipratropium bromide (Atrovent) is delivered by MDI?A. 10 mg/puffB. 15 mg/puffC. 18 mg/puffD. 90 mg/puff
![Page 28: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/28.jpg)
What is the dosage for Ipratropium bromide (Atrovent)?A. 2 puffs qidB. 2 puffs tidC. 2 puffs bidD. 2 puffs q12h
![Page 29: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/29.jpg)
What is the dosage for Ipratropium bromide (Atrovent)?A. 2 puffs qidB. 2 puffs tidC. 2 puffs bidD. 2 puffs q12h
![Page 30: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/30.jpg)
What are some common side effects seen with Ipratropium bromide (Atrovent)?A. TachycardiaB. Blood pressure increaseC. Cough and dry mouthD. Tolerance
![Page 31: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/31.jpg)
What are some common side effects seen with Ipratropium bromide (Atrovent)?A. TachycardiaB. Blood pressure increaseC. Cough and dry mouthD. Tolerance
![Page 32: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/32.jpg)
Which of the following are indications for use of acetylcysteine (Mucomyst)?
I. Treatment of acetaminophen overdoseII. Treatment of excessive, viscous mucus
secretionsIII. Treatment of aspirin overdoseIV.Treatment of purulent mucus secretions by
breaking up DNA
A. I and II onlyB. II and IV onlyC. I, II, and IIID. I, II, III, and IV
![Page 33: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/33.jpg)
Which of the following are indications for use of acetylcysteine (Mucomyst)?
I. Treatment of acetaminophen overdoseII. Treatment of excessive, viscous mucus
secretionsIII. Treatment of aspirin overdoseIV.Treatment of purulent mucus secretions by
breaking up DNA
A. I and II onlyB. II and IV onlyC. I, II, and IIID. I, II, III, and IV
![Page 34: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/34.jpg)
Acetylcysteine (Mucomyst) lowers the viscosity of mucus by means of which of the following?
A.Breaking down DNAB.Increasing the osmolarity of the mucus and
pulling water into itC.Changing the pH of the mucus, causing it to
break downD.Substituting its sulfhydryl group for disulfide
bonds and breaking a portion of the bond forming the gel structure
![Page 35: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/35.jpg)
Acetylcysteine (Mucomyst) lowers the viscosity of mucus by means of which of the following?
A.Breaking down DNAB.Increasing the osmolarity of the mucus and
pulling water into itC.Changing the pH of the mucus, causing it to
break downD.Substituting its sulfhydryl group for disulfide
bonds and breaking a portion of the bond forming the gel structure
![Page 36: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/36.jpg)
Which of the following should be assessed when delivering acetylcysteine (Mucomyst)?
I. Presence of adverse effects that require treatment to be discontinued
II. Monitoring peak flow changesIII. Monitoring color, consistency, and amount of sputumIV. Monitoring for presence of hydrogen sulfide (a rotten
egg odor), which means that the acetylcysteine (Mucomyst) is no longer active
A. I and III onlyB. I, II, and IIIC. II, III, and IVD. I, II, III, and IV
![Page 37: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/37.jpg)
Which of the following should be assessed when delivering acetylcysteine (Mucomyst)?
I. Presence of adverse effects that require treatment to be discontinued
II. Monitoring peak flow changesIII. Monitoring color, consistency, and amount of sputumIV. Monitoring for presence of hydrogen sulfide (a rotten
egg odor), which means that the acetylcysteine (Mucomyst) is no longer active
A. I and III onlyB. I, II, and IIIC. II, III, and IVD. I, II, III, and IV
![Page 38: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/38.jpg)
Which of the following are true regarding glucocorticoids?
I. They work through activation of intracellular receptors.
II. Relief is immediate.III. Daily compliance is essential to controlling
inflammation in asthma.IV.Taken intranasally they can control allergic and
nonallergic rhinitis.A. I, II, and IIIB. I, III, and IVC. II, III, and IVD. I, II, III, and IV
![Page 39: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/39.jpg)
Which of the following are true regarding glucocorticoids?
I. They work through activation of intracellular receptors.
II. Relief is immediate.III. Daily compliance is essential to controlling
inflammation in asthma.IV.Taken intranasally they can control allergic and
nonallergic rhinitis.A. I, II, and IIIB. I, III, and IVC. II, III, and IVD. I, II, III, and IV
![Page 40: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/40.jpg)
How does cromolyn sodium work?A.Producing antiinflammatory enzymes within
cellsB.Inhibiting degranulation of mast cellsC.Preventing arachidonic acid formation from
activation of mast cell membrane phospholipase A2
D.Leukotriene inhibition
![Page 41: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/41.jpg)
How does cromolyn sodium work?A.Producing antiinflammatory enzymes within
cellsB.Inhibiting degranulation of mast cellsC.Preventing arachidonic acid formation from
activation of mast cell membrane phospholipase A2
D.Leukotriene inhibition
![Page 42: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/42.jpg)
Which of the following is true about the use of Ribavirin?
I. It is used as an antiviral agent against influenza.II. It is delivered by a SPAG unit.III. Adverse effects include skin rash, conjunctivitis,
and eyelid erythema.IV.It can occlude endotracheal-tube and ventilator
exhalation valves.
A. I, and II onlyB. III and IV onlyC. II, III, and IVD. I, II, III, and IV
![Page 43: Pharmacology](https://reader036.fdocuments.in/reader036/viewer/2022062309/56814c0c550346895db90a6f/html5/thumbnails/43.jpg)
Which of the following is true about the use of Ribavirin?
I. It is used as an antiviral agent against influenza.II. It is delivered by a SPAG unit.III. Adverse effects include skin rash, conjunctivitis,
and eyelid erythema.IV.It can occlude endotracheal-tube and ventilator
exhalation valves.
A. I, and II onlyB. III and IV onlyC. II, III, and IVD. I, II, III, and IV